Matthew Bresnahan

Co-Chair of Goodwin’s San Diego office, Matthew Bresnahan helps biotechnology, therapeutics, medical device, and diagnostics companies build intellectual property strategies that drive innovation and business growth. Over the past two decades, he has developed patent strategies supporting more than 50 drugs and therapeutic candidates and serves as outside general IP counsel to more than 50 life sciences companies across California. Matt regularly advises clients on portfolio development, high-stakes IP diligence, financings, licensing transactions, IPOs, M&A, strategic IP litigation, freedom-to-operate analyses, and inter partes review (IPR) proceedings. He also counsels boards and executive teams on patent and business strategy, translating complex scientific and commercial objectives into durable intellectual property portfolios that support long-term growth. As Goodwin continues to expand its Life Sciences platform on the West Coast, Matt plays a central leadership role in building the firm’s California practice and serving innovative companies throughout the region.